Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 27, 2015 9:57 AM ET

Pharmaceuticals

Company Overview of Pernix Sleep, Inc.

Company Overview

Pernix Sleep, Inc., a specialty pharmaceutical company, engages in developing and commercializing prescription therapeutics to treat medical conditions. The company focuses on in-licensing, developing, and marketing proprietary products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. Its products include Silenor, a nonscheduled prescription medication for the treatment of sleep maintenance insomnia, which include adults and the elderly who have sleep maintenance insomniaA type of insomnia, people with chronic sleep maintenance insomnia (insomnia lasting more than three weeks), and people with transient insomnia. Th...

10935 Vista Sorrento Parkway

Suite 250

San Diego, CA 92130

United States

Founded in 2003

36 Employees

Phone:

858-876-6500

Fax:

858-509-1761

Key Executives for Pernix Sleep, Inc.

Chief Executive Officer, President and Director
Age: 50
Co-Founder
Age: 65
Chief Financial Officer, Principal Accounting Officer and Senior Vice President
Age: 40
Senior Vice President, General Counsel and Secretary
Age: 43
Senior Vice President of Technical Operations
Age: 45
Compensation as of Fiscal Year 2014.

Pernix Sleep, Inc. Key Developments

Pernix Sleep, Inc., Annual General Meeting, Jun 19, 2013

Pernix Sleep, Inc., Annual General Meeting, Jun 19, 2013., at 11:00 US Eastern Standard Time. Location: Pernix Therapeutics Holdings, Inc.. Agenda: To elect five directors for a term of one year; to approve, on an advisory basis, the company's executive compensation; to indicate, on an advisory basis, how frequently the company should hold an advisory vote on executive compensation; to ratify the selection of Cherry Bekaert LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2013; and to transact such other business as may properly come before the meeting or any postponement or adjournment thereof.

Similar Private Companies By Industry

Company Name Region
The Mentholatum Company, Inc. United States
Meridian Labs, Inc. United States
Nivalis Therapeutics, Inc. United States
Traxion Therapeutics, Inc. United States
LQ3 Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Pernix Sleep, Inc., please visit www.somaxon.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.